Chris Bartlett, Ph.D. - Publications
Affiliations: | 2006 | University of North Carolina, Chapel Hill, Chapel Hill, NC |
Area:
Toxicology, GeneticsYear | Citation | Score | |||
---|---|---|---|---|---|
2014 | Song S, Walter V, Karaca M, Li Y, Bartlett CS, Smiraglia DJ, Serber D, Sproul CD, Plass C, Zhang J, Hayes DN, Zheng Y, Weissman BE. Gene silencing associated with SWI/SNF complex loss during NSCLC development. Molecular Cancer Research : McR. 12: 560-70. PMID 24445599 DOI: 10.1158/1541-7786.Mcr-13-0427 | 0.58 | |||
2011 | Bartlett C, Orvis TJ, Rosson GS, Weissman BE. BRG1 mutations found in human cancer cell lines inactivate Rb-mediated cell-cycle arrest. Journal of Cellular Physiology. 226: 1989-97. PMID 21520050 DOI: 10.1002/Jcp.22533 | 0.565 | |||
2005 | Rosson GB, Bartlett C, Reed W, Weissman BE. BRG1 loss in MiaPaCa2 cells induces an altered cellular morphology and disruption in the organization of the actin cytoskeleton. Journal of Cellular Physiology. 205: 286-94. PMID 15887247 DOI: 10.1002/Jcp.20397 | 0.584 | |||
2005 | Banine F, Bartlett C, Gunawardena R, Muchardt C, Yaniv M, Knudsen ES, Weissman BE, Sherman LS. SWI/SNF chromatin-remodeling factors induce changes in DNA methylation to promote transcriptional activation. Cancer Research. 65: 3542-7. PMID 15867346 DOI: 10.1158/0008-5472.Can-04-3554 | 0.564 | |||
2003 | Hummer BT, Bartlett C, Henry E, Weissman BE. Expression of Smad4 in the FaDu cell line partially restores TGF-beta growth inhibition but is not sufficient to regulate fibronectin expression or suppress tumorigenicity. Journal of Cellular Physiology. 194: 289-302. PMID 12548549 DOI: 10.1002/Jcp.10202 | 0.402 | |||
Show low-probability matches. |